Iron deficiency in toddlers: common, consequential, and awkward to screen for

Iron deficiency is the most common cause of anaemia in early childhood, and anaemia affects an estimated 40% of children aged 6 to 59 months worldwide [s1]. It is repeatedly linked to poorer thinking and movement in young children — but the evidence that screening a symptom-free toddler, or routinely giving toddlers iron, actually protects their development is surprisingly weak [s2][s3][s4].

Why iron matters in the first years

Iron is needed to make haemoglobin, the protein in red blood cells that carries oxygen; when the body runs short, the number of red cells or the amount of haemoglobin in them falls below normal, and that is anaemia [s1]. In many low- and lower-middle-income settings the most commonly recognised causes are iron deficiency and malaria [s1]. The concern in the first years of life is not just the blood count: in severe cases anaemia can cause poor cognitive and motor development in children, which is why iron status in infancy and toddlerhood gets so much attention [s1].

The American Academy of Pediatrics puts the developmental worry more sharply. Its clinical report on children from birth through three years states that recent basic research supports the concern that iron-deficiency anaemia — and iron deficiency without anaemia — during infancy and childhood can have long-lasting detrimental effects on neurodevelopment [s2]. That last phrase matters: it means the depletion may bite before the haemoglobin number drops far enough to flag as anaemia on a standard test [s2].

The screening problem

If iron deficiency is common and potentially harmful, the intuitive move is to test every toddler. The evidence does not clearly support that. The US Preventive Services Task Force reviewed screening for iron-deficiency anaemia in children aged 6 to 24 months who live in the United States and are asymptomatic, and concluded that the current evidence is insufficient to assess the balance of benefits and harms — a formal "I statement" [s3]. That recommendation deliberately excludes children who were born prematurely or with low birth weight, who were severely malnourished, or who already have symptoms [s3]; those groups are a different question. But for the average well toddler, the Task Force found the case for or against universal screening genuinely unproven [s3].

This is not the same as saying iron does not matter. It is the narrower, more honest point that a screening programme has to show it improves outcomes, and for symptom-free toddlers that link — from a blood test, through treatment, to a healthier child — has not been demonstrated to the Task Force's standard [s3].

Does treating deficiency help the brain?

Here the largest analysis delivers a split verdict. A systematic review pooled 35 studies of daily oral iron in children aged 4 to 23 months, covering 42,306 children [s4]. On the blood, iron worked and worked well: compared with control, the risk ratio for anaemia was 0.61 (95% confidence interval 0.50 to 0.74), for iron deficiency 0.30 (0.15 to 0.60), and for iron-deficiency anaemia 0.14 (0.10 to 0.22) [s4]. In other words, daily iron sharply cut the deficiency it targets.

The developmental payoff was the part that did not follow. Pooling six trials, the review found no evidence of a difference in mental development scores between supplemented and control children — a mean difference of 1.65 points (95% CI −0.63 to 3.94), an interval straddling zero [s4]. So supplementation reliably fixed the laboratory problem while leaving the outcome parents most care about unproven in these data [s4]. The authors also noted that only a minority of the trials were judged to be at low risk of bias, and that about 47% of preschool children worldwide are anaemic — a reminder that this is a mass problem, not a niche one [s4].

How to read this

The defensible summary is layered rather than tidy. Iron deficiency in toddlers is genuinely common and is associated with worse cognitive and motor development, and the biology behind that association is well understood [s1][s2]. What is weaker is the evidence that intervening on a well, symptom-free toddler — by screening or by routine supplements — changes the developmental trajectory, as opposed to correcting the blood test [s3][s4]. That gap is exactly the kind of thing marketing for infant iron products glosses over.

Diet is where most of the action sits: iron-rich first foods and the timing of solids shape a toddler's intake, questions we take up in baby-led weaning versus spoon-feeding. The same nutrient behaves very differently later in life — the drivers and the treatment debate in adults are covered in iron deficiency in menstruating women — and the broader trade-offs of diets that limit animal foods, iron among them, are set out in plant-based eating and nutrient gaps.

This article is informational and is not medical advice. A child who is pale, tired, feeding poorly or failing to grow should be assessed by a qualified clinician rather than started on any supplement on the strength of a general article; iron in excess is itself hazardous to small children [s2].